SEC Form 4 · accession 0001193125-26-380595
AN2 Therapeutics, Inc. · ANTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret M FitzPatrick
Director
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 6:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001880438
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2026 | P | 2,098 | $5.53 | A | 10,708 | D |
Table II — derivative securities
No Table II lines on this filing.